[
  {
    "date": "2023-12-31",
    "symbol": "NRSNW",
    "period": "FY",
    "cashandcashequivalents": 2640000,
    "othercurrentreceivables": 236000,
    "shorttermdepositsclassifiedascashequivalents": 40000,
    "currentassets": 2916000,
    "propertyplantandequipment": 85000,
    "rightofuseassets": 153000,
    "noncurrentnoncashassetspledgedascollateralforwhichtransfereehasrightbycontractorcustomtosellorrepledgecollateral": 22000,
    "noncurrentassets": 260000,
    "assets": 3176000,
    "tradeandothercurrentpayablestotradesuppliers": 1459000,
    "othercurrentpayables": 2000000,
    "currentliabilities": 3459000,
    "noncurrentleaseliabilities": 73000,
    "noncurrentgovernmentgrants": 1518000,
    "noncurrentliabilities": 1591000,
    "liabilities": 5050000,
    "sharepremium": 30192000,
    "retainedearnings": -32066000,
    "equity": -1874000,
    "equityandliabilities": 3176000,
    "researchanddevelopmentsexpenses": 7588000,
    "generalandadministrativeexpense": 5714000,
    "profitlossfromoperatingactivities": -13302000,
    "financecosts": 2209000,
    "financeincome": 4231000,
    "financeincomecost": 2022000,
    "comprehensiveincome": -11280000,
    "basicearningslosspershare": -0.83,
    "dilutedearningslosspershare": -0.83,
    "increasedecreasethroughsharebasedpaymenttransactions": 2959000,
    "netlossandcomprehensiveloss": -11280000,
    "exerciseofoption": 5000,
    "exerciseofprefundedwarrants": 1670000,
    "profitloss": -11280000,
    "adjustmentsfordepreciationexpense": 97000,
    "adjustmentsforsharebasedpayments": 2798000,
    "adjustmentsforfairvaluegainslosses": -4036000,
    "day1lossfromissuanceoffinancialinstruments": 1659000,
    "financeexpenseincome": -402000,
    "increaseinotherreceivables": -19000,
    "adjustmentsforincreasedecreaseintradeaccountpayable": 961000,
    "adjustmentsforincreasedecreaseinotheroperatingpayables": 928000,
    "cashflowsfromusedinoperatingactivities": -8452000,
    "interestreceivedclassifiedasinvestingactivities": 178000,
    "purchaseofpropertyplantandequipmentclassifiedasinvestingactivities": 29000,
    "cashflowsfromusedindecreaseincreaseinshorttermdepositsandinvestments": 3500000,
    "investmentinrestricteddeposits": 3000,
    "cashflowsfromusedininvestingactivities": 3646000,
    "proceedsfromexerciseofoptions": 5000,
    "repaymentsofborrowingsclassifiedasfinancingactivities": 80000,
    "proceedsfromissuingshares": 3970000,
    "cashflowsfromusedinfinancingactivities": 3895000,
    "effectofexchangeratechangesoncashandcashequivalents": 8000,
    "increasedecreaseincashandcashequivalents": -903000,
    "cashandcashequivalentsclassifiedaspartofdisposalgroupheldforsale": 2640000,
    "sharebasedpaymentmodification": 161000,
    "proceedsfromexerciseofwarrants": 823000,
    "scheduleofregardingtheexchangerateofthenewisraelishekeltabletextblock": "Below are details regarding the exchangerate of the New Israeli Shekel (“NIS”), the Euro and the GBP:",
    "scheduleofcash": "December 31, 2023      December 31, 2022             U.S. dollars in thousands       Denominated in NIS     $107      $229       Denominated in USD      *2,533      3,309       Denominated in EUR      -       1       Denominated in GBP      -       4             $2,640      $3,543",
    "disclosureofotherreceivablestabletextbock": "December 31,    2023              December 31,    2022                     U.S. dollars    in thousands            Government agencies         $    29              $    24           Prepaid expenses              70                   124           Other              137                   107                     $    236              $    255",
    "scheduleofpublicpropertyplantandequipmenttabletextblock": "Balance as of December 31, 2023:",
    "disclosureofmaturityanalysisofleaseliabilitytabletextblock": "Maturity analysis of the Company’s lease liabilities",
    "scheduleofweightedaverageremainingleasetermsanddiscountratetabletextblock": "The following is a summary of weighted average remaininglease terms and discount rate for Company’s leases:",
    "scheduleofamountsrecognizedinprofitorlosstabletextblock": "The following are the amounts recognized in profit or loss:",
    "scheduleofleasepaymentstabletextblock": "Presented hereunder are the lease payments the Company paidin the year ended December 31, 2023, 2022 and 2021:",
    "disclosurescheduleofotherpayablestabletextblock": "December 31,             2023      2022             U.S. dollars in thousands       Employees and payroll accruals (*)     $1,317      $751       Short term lease liability      69       64       Accrued expenses      614       413             $2,000      $1,228",
    "scheduleoffairvalueoftheoptionsgrantedtabletextblock": "The following table lists the inputsused for calculation of fair value of the options granted to employees and directors for the years ended December 31, 2023, 2022 and2021:",
    "scheduleofrestrictedstockunitrsusactivityexplanatory": "The following table summarizes the RSU’s activityfor the annual periods ended on December 31, 2023 and 2022:",
    "scheduleofsharebasedexpenserecognizedinthestatementsofincometabletextblock": "The share-based expense recognized in the statements ofincome were as follows:",
    "scheduleofresearchanddevelopmentexpensestabletextblock": "For the year ended December 31,             2023      2022      2021             U.S. dollars in thousands       Subcontractors and consultants     $4,793      $3,612      $628       Share-based compensation      889       1,592       1,969       Salaries and social benefits (see also note 12)      1,905       1,212       447       Others      1       -       38             $7,588      $6,416      $3,082",
    "scheduleofgeneralandadministrativeexpensestabletextblock": "For the year ended December 31,             2023      2022      2021             U.S. dollars in thousands       Professional services     $1,486      $1,085      $372       Share-based compensation      1,909       3,513       1,849       Salaries and social benefits (*)      1,011       837       74       Insurance      511       1,174       68       Traveling abroad      164       165       50       Others      633       362       92             $5,714      $7,136      $2,505",
    "scheduleofbalanceswithrelatedpartiestabletextblock": "A.",
    "scheduleoftransactionswithrelatedpartiestabletextblock": "B.",
    "scheduleofactstoreducetheforeignexchangerisktabletextblock": "The Company acts to reduce the foreignexchange risk by managing an adequate part of the available liquid sources in or linked to the NIS.",
    "disclosureofmovementinwarrantliabilityexplanatory": "The following table summarizes the movement in warrant liability during2023 and 2022:",
    "closingforeignexchangerate": 1.1,
    "exchangeratepercentage": 0.025,
    "estimatedusefullivesterm": 0.33,
    "explanationoffactthatcarryingamountofgoodwillorintangibleassetswithindefiniteusefullivesisnotsignificant": "The shorter of the lease term and the useful life",
    "cash": 107000,
    "governmentagencies": 29000,
    "currentprepaidexpenses": 70000,
    "otherreceivables": 137000,
    "tradeandotherreceivables": 236000,
    "costbalances": 92000,
    "amountsincurreddeferredacquisitioncostsarisingfrominsurancecontracts": 26000,
    "accumulatedothercomprehensiveincome": 34000,
    "depreciationpropertyplantandequipment": 20000,
    "depreciatedcost": 58000,
    "depreciationrightofuseassets": 76000,
    "grossleaseliabilities": 69000,
    "currentleaseliabilities": 69000,
    "weightedaveragedurationofdefinedbenefitobligation2019": "P2Y",
    "weightedaveragediscountrate": 0.06,
    "interestexpenseonleaseliabilities": 11000,
    "amortisationexpense": 76000,
    "otheradjustmentstoreconcileprofitloss": 87000,
    "leasepayments": 80000,
    "leasepaymentstotal": 80000,
    "shorttermemployeebenefitsaccruals": 1317000,
    "shorttermleaseliability": 69000,
    "currentaccruedexpensesandothercurrentliabilities": 614000,
    "otherpayables": 2000000,
    "numberofsharesauthorised": 60000000,
    "numberofsharesissuedandpaid": 15379042,
    "numberofsharesissuedandfullypaid": 15379042,
    "vestedrestrictedstockunits": -467479,
    "issuedforcashduringtheperiod": 3600,
    "exerciseofsharewarrantsandoptionsduringtheyear": -126000,
    "issuanceofshares": 1330000,
    "descriptionofexpectedvolatilityshareoptionsgranted": 0.918,
    "exercisepriceshareoptionsgranted2019": 0.96,
    "weightedaveragesharepriceshareoptionsgranted2019": 0.96,
    "descriptionofriskfreeinterestrateshareoptionsgranted": 0.0435,
    "weightedaverageremainingcontractuallifeofoutstandingshareoptions2019": "P10Y",
    "numberofoutstandingshareoptions": 1069128,
    "weightedaverageexercisepriceofshareoptionsoutstandinginsharebasedpaymentarrangement2019": 2.34,
    "numberofshareoptionsgrantedinsharebasedpaymentarrangement": 82628,
    "weightedaverageexercisepriceofshareoptionsgrantedinsharebasedpaymentarrangement2019": 1.1,
    "numberofshareoptionsexercisedinsharebasedpaymentarrangement": 126000,
    "weightedaverageexercisepriceofshareoptionsexercisedinsharebasedpaymentarrangement2019": 0.03,
    "numberofshareoptionsforfeitedinsharebasedpaymentarrangement": 48000,
    "weightedaverageexercisepriceofshareoptionsforfeitedinsharebasedpaymentarrangement2019": 2.09,
    "numberofshareoptionsexercisableinsharebasedpaymentarrangement": 652878,
    "weightedaverageexercisepriceofshareoptionsexercisableinsharebasedpaymentarrangement2019": 2.32,
    "numberofoutstandingshareoption": 317000,
    "researchanddevelopmentexpense": 889000,
    "sellinggeneralandadministrativeexpense": 1909000,
    "subcontractorsandconsultants": 4793000,
    "sharebasedcompensation": 889000,
    "salariesandsocialbenefits": 1905000,
    "researchanddevelopmentexpenseothers": 1000,
    "researchanddevelopmentexpensestotal": 7588000,
    "professionalfeesexpense": 1486000,
    "sharesbasedcompensation": 1909000,
    "benefitspaidorpayable": 1011000,
    "insuranceexpense": 511000,
    "travelexpense": 164000,
    "otherexpensebynature": 633000,
    "othergainslosses": 5714000,
    "revaluationofwarrants": 4036000,
    "interestincomeondeposits": 178000,
    "gainslossesonexchangedifferencesontranslationnetoftax": 17000,
    "reclassificationadjustmentsonexchangedifferencesontranslationnetoftax": 4231000,
    "insurancefinanceincomeexpensesfrominsurancecontractsissuedexcludedfromprofitorlossthatwillbereclassifiedtoprofitorlossnetoftax": -530000,
    "interestsexpensesonleaseliability": -11000,
    "othercomprehensiveincomenetoftaxinsurancefinanceincomeexpensesfrominsurancecontractsissuedexcludedfromprofitorlossthatwillbereclassifiedtoprofitorloss": -9000,
    "shareofothercomprehensiveincomeofassociatesandjointventuresaccountedforusingequitymethodthatwillbereclassifiedtoprofitorlossnetoftax": -2209000,
    "tradeandothercurrentpayables": 1012000,
    "amountspayablerelatedpartytransactions": 1012000,
    "wagesandsalaries": 1932000,
    "dividendspaid": 310000,
    "keymanagementpersonnelcompensationsharebasedpayment": 2503000,
    "purchasesofgoodsrelatedpartytransactions": 4745000,
    "numberofrelatedparties": 5000,
    "numberofdirectors": 5000,
    "sharesofordinaryshareusedincomputingbasicnetlosspershare": 13640168,
    "sharesofordinaryshareusedincomputingdilutednetlosspershare": 13640168,
    "weightedaveragenumberofordinaryshares": 11781963,
    "dilutiveeffectofshareoptionsonnumberofordinaryshares": 929334,
    "increasedecreaseinnumberofordinarysharesissued": 928871,
    "cashonhand": 2533000,
    "longtermdeposits": 40,
    "othernoncurrentfinancialassets": 22,
    "financialliabilities": 73,
    "financialliabilitiesatfairvalue": 1518000,
    "totalnetexposureinstatementoffinancialpositioninrespectoffinancialassetsandfinanciallia": -703000,
    "profitlossattributabletoownersofparent": -134000,
    "profitlossattributabletoordinaryequityholdersofparententityincludingdilutiveeffects": -134000,
    "expectedlife": "P4Y5M19D",
    "warrantliabilityrecognition": 4500000,
    "fairvaluerevaluationwarrantliability": -4036000,
    "adjustmentsforfinancecosts": 1659000,
    "exerciseinwarrantliability": -823000,
    "numberofemployee": 16,
    "rentalincome": 7000,
    "liabilitiesfromsharebasedpaymenttransactions2011": 209000,
    "sharepurchaseagreements": "a.",
    "warrantstoinvestorsdescription": "In August and September 2021after the said assignments, the Company received warrant exercise notices of 1,837,500 warrants, out of the total 2,130,000 warrantsoutstanding at that time. The other 292,500 warrants that were not exercised were waived by their owners. As a result of the saidexercises, the Company received aggregate proceeds of $1,225 thousand.",
    "numberofsharesoutstanding": 3600,
    "othernoncurrentreceivables": 47000,
    "netproceedsfromoffering": 9864000,
    "exerciseofunderwritersoption": 3000,
    "grossproceed": 7000,
    "immediatelossamount": 1659000,
    "considerationwarrantsandprefundedwarrantamount": 4500000,
    "ordinarysharesvotingrights": "Each ordinary share is entitled toone vote.",
    "expirationdateoftheoptionsgrantedtoemployeesanddirectors": "P10Y",
    "sharesreservedforissueunderoptionsandcontractsforsaleofshares": 1151130,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailablegrant": 233543,
    "weightedaveragecostofcapitalpercentage": 0.6,
    "pensionfunds": 104000,
    "annualinterestrate": 0.023,
    "warrantsoutstandingshares": 4755000,
    "percentageoftaxrates": 0.23,
    "gainslossesonchangeinvalueofforwardelementsofforwardcontractsbeforetax": 17420000,
    "entityregistrantname": "NeuroSense Therapeutics Ltd.",
    "tradingsymbol": "NRSN",
    "documenttype": "20-F",
    "currentfiscalyearenddate": "--12-31",
    "entitycommonstocksharesoutstanding": 15379042,
    "amendmentflag": "false",
    "entitycentralindexkey": 1875091,
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entityfilercategory": "Non-accelerated Filer",
    "entitywellknownseasonedissuer": "No",
    "documentperiodenddate": "2023-12-31",
    "documentfiscalyearfocus": 2023,
    "documentfiscalperiodfocus": "FY",
    "entityemerginggrowthcompany": "true",
    "entityshellcompany": "false",
    "entityextransitionperiod": "false",
    "icfrauditorattestationflag": "false",
    "documentregistrationstatement": "false",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "documentshellcompanyreport": "false",
    "entityfilenumber": "001-41084",
    "entityincorporationstatecountrycode": "L3",
    "entityaddressaddressline1": "11 HaMenofim Street",
    "entityaddressaddressline2": "Building B",
    "entityaddresscityortown": "Herzliya",
    "entityaddresspostalzipcode": 4672562,
    "entityaddresscountry": "IL",
    "contactpersonnelname": "Or Eisenberg",
    "cityareacode": 972,
    "localphonenumber": "-9-7996183",
    "security12btitle": "Ordinary Shares, no par value per share",
    "securityexchangename": "NASDAQ",
    "entityinteractivedatacurrent": "Yes",
    "documentfinstmterrorcorrectionflag": "false",
    "documentaccountingstandard": "International Financial Reporting Standards",
    "auditorfirmid": 1057,
    "auditorname": "Somekh Chaikin",
    "auditorlocation": "Tel-Aviv, Israel"
  }
]